A Randomized Crossover TrIal to Compare Recombinant Human rhPTH(1-34) to the ASsociation Alfacalcidol/Hydrochlorothiazide in the Treatment of Severe Primary Hypoparathyroidism
Latest Information Update: 03 Oct 2021
At a glance
- Drugs Teriparatide (Primary) ; Alfacalcidol; Amiloride; Hydrochlorothiazide
- Indications Hypocalcaemia; Hypoparathyroidism
- Focus Therapeutic Use
- Acronyms ACTICAS
- 12 Jun 2020 Status changed from recruiting to completed.
- 19 Jun 2017 Planned End Date changed from 1 Nov 2019 to 1 Aug 2020.
- 19 Jun 2017 Planned primary completion date changed from 1 Nov 2019 to 1 Aug 2020.